Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFH4L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,151
Award facts
- Contract value 100% obligated
- $10,151.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,151.29 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on December 4, 2025, with completion expected by December 5, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. Dupixent is a specialty pharmaceutical used to treat atopic dermatitis, asthma, and other inflammatory conditions, reflecting the company's broader portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The parent SPE2DX contract positions AmerisourceBergen to supply comprehensive pharmaceutical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, demonstrating the vendor's established capability to meet federal medical supply requirements through open competition.
Quick answers
Who was awarded contract SPE2DR26FFH4L?
SPE2DR26FFH4L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26FFH4L worth?
The government has obligated $10,151 on SPE2DR26FFH4L.
Is contract SPE2DR26FFH4L an order under another contract?
Yes. SPE2DR26FFH4L is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFH4L competed?
The extent of competition for SPE2DR26FFH4L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award